Assignee
DONOVAN DAVID M
US·7 granted patents·26 citations·filing 2009–2012
Top patents by PatentIndex Score
7 records- 0190US8481289B2Triple acting antimicrobials that are refractory to resistance developmentDONOVAN DAVID M·Filed 2009·Granted Jul 9, 2013·12 cites·10 claims
- 0287US8568714B2Lys K endolysin is synergistic with lysostaphin against MRSADONOVAN DAVID M·Filed 2009·Granted Oct 29, 2013·8 cites·8 claims
- 0382US9545431B1Isolated recombinant cDNADONOVAN DAVID M·Filed 2009·Granted Jan 17, 2017·2 cites·12 claims
- 0468US9206411B2Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureusDONOVAN DAVID M·Filed 2012·Granted Dec 8, 2015·1 cites·8 claims
- 0565US8790639B2Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysinDONOVAN DAVID M·Filed 2012·Granted Jul 29, 2014·2 cites·17 claims
- 0659US8986695B2Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5DONOVAN DAVID M·Filed 2011·Granted Mar 24, 2015·1 cites·13 claims
- 0737US8980614B2Staphylococcus haemolyticus prophage φSH2 endolysin is lytic for Staphylococcus aureusDONOVAN DAVID M·Filed 2012·Granted Mar 17, 2015·0 cites·9 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →